In 2016, a landmark study by Nioi et al.3 found that a loss of function variant of ASGR1 caused by a noncoding 12-base-pair (bp) deletion (del12) reduced non-HDL cholesterol and protected against the development of atherosclerosis. This evidence concerns the gene ASGR1 and atherosclerosis.